The operation, which will allow Sciclone to use technology developed by Intelligent Pharma to better understand how specific molecules work, will help drivethe Catalan biotechnology company’s international expansion.
Catalan Telstar and British Puretech Process Systems have been strategic partners since the end of last year. Jordi Net, Telstar Sales Marketing Director says, “The new brand is synonymous with high quality and lower life-cycle prices.”
Investors in the Ysios BioFund I will see the first returns on their investment, many before the 5 to 7 years that constitute the average in the venture capital sector.
Invest in Spain offers aid valued at 1,600,000 euros for companies that start up operations in any region of the country or those already established that begin R&D&i activities.